NCT00006039View on ClinicalTrials.gov

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

March 31, 2001

Study Completion Date

March 31, 2001

Conditions
LymphomaSmall Intestine Cancer
Interventions
BIOLOGICAL

pegylated interferon alfa

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006039 - Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter